Clinical Trials Logo

Filter by:
NCT ID: NCT06339138 Recruiting - Clinical trials for Urothelial Carcinoma

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Start date: February 20, 2018
Phase:
Study type: Observational

This study is being done to collect blood, tissue and urine samples to identify a novel high quality methylated DNA marker in patients with renal tumors.

NCT ID: NCT06339034 Not yet recruiting - Parkinson Disease Clinical Trials

Repurposing Lithium for Parkinson's Disease: a RCT

Start date: June 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.

NCT ID: NCT06339008 Recruiting - Clinical trials for Perennial Allergic Rhinitis (PAR)

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

Start date: April 26, 2024
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. The study will last about 18 months

NCT ID: NCT06338995 Recruiting - Clinical trials for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Start date: April 29, 2024
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.

NCT ID: NCT06338865 Recruiting - Clinical trials for Laparoscopic Surgery

Short Title: Standard vs. Lower Pressure Pneumoperitoneum

Start date: May 3, 2024
Phase: N/A
Study type: Interventional

This study aims to investigate the effect of varying insufflation pressures on post-operative pain and adequacy of surgical field visualization among patients undergoing laparoscopic surgery with a minimally invasive gynecologic surgeon.

NCT ID: NCT06338774 Not yet recruiting - Physical Inactivity Clinical Trials

Cognitive Control to Boost Physical Activity Adherence

BOOST
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

This trial is designed to develop and test the efficacy of cognitive training strategies to improve self-regulatory capacities for middle-aged adults to adopt and sustain a physically active lifestyle. The main questions it aims to answer are: - Can cognitive training designed to improve cognitive control improve physical activity adherence? - What are the psychological, physiological, cognitive, and sociodemographic factors that affect the impact of cognitive control on physical activity adherence? Participants will - Complete a 6-week home-based, computerized cognitive training program - Complete a 6-week home-based, aerobic exercise training program with supervision of a health coach and trainer - Complete a 6-week home-based, aerobic exercise training program prescribed by a health coach and trainer - Visit the laboratory before and after cognitive training, and before and after physical training, to complete assessments of cognition and aerobic fitness

NCT ID: NCT06338748 Not yet recruiting - Clinical trials for Continuous Glucose Monitoring

Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery

DexcomG7
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

This is a prospective longitudinal study to study the agreement between a continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the Cardiovascular Intensive Care Unit (CVICU), and by Point of Care (POC) fingerstick glucose using the Accucheck Inform II on the regular floors, and the CGMS reading at the same time will be captured. Subjects will have measurements taken throughout their stay in the CVICU and on the regular floors. Agreement and correlation between systems, as well as errors, will be calculated.

NCT ID: NCT06338722 Recruiting - Clinical trials for Scleroderma, Systemic

Making it Work Program for Systemic Sclerosis

Start date: December 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to see if an online intervention program for people with Systemic Sclerosis (scleroderma) helps keep people in the workforce and increase self-confidence in dealing with challenges at work. The program is called Making it Work Systemic Sclerosis. Researchers will compare a group who gets the program to a group who will get the program at a later point in time (wait list control group) to see if self-confidence in dealing with work challenge gets better. People in the Making it Work group will complete questionnaires and attend one 2 hour meetings each week for 5 weeks and meet with an occupational therapist and vocational counselor. People in the wait list control group will complete the questionnaires and participate in the program at a later point in time.

NCT ID: NCT06338657 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer

Start date: April 1, 2024
Phase: Phase 1
Study type: Interventional

This phase I trial studies on how the PEOX-based polymer encapsulated paclitaxel FID-007 (FID-007) affects the immune cells around the tumor patients with head and neck squamous cell carcinoma. The active drug in FID-007 is paclitaxel, an established chemotherapy drug that has been shown to kill cancer cells. FID-007 is a packaged form of paclitaxel using a polyethylozaxoline (PEOX) polymer which may allow the drug to reach deeper into tumors and less into normal cells by being smaller. This study is being done to help identify future treatment options and better understand how to improve outcomes of patients with head and neck cancers after surgery.

NCT ID: NCT06338592 Recruiting - Lung Cancer Clinical Trials

The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale

MyLungHealth
Start date: March 28, 2024
Phase: N/A
Study type: Interventional

Early lung cancer screening (LCS) through low-dose computed tomography (LDCT) is crucial but underused due to various barriers, including incomplete or inaccurate patient smoking data in the electronic health record and limited time for shared decision-making. The objective of this trial is to investigate a patient-centered intervention, MyLungHealth, delivered through the patient portal. The intervention is designed to improve LCS rates through increased identification of eligible patients and informed decision making.